Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death

Abstract

Objectives: There is no consensus on specific serum 25-hydroxy vitamin D (25(OH) D) levels associated with higher risk of severe outcome in patients with coronavirus disease 2019 (COVID-19). According to the literature patients with serum 25(OH) D levels 12 ng/ml (p <0.05). Conclusions: Patients with COVID-19 with serum 25(OH) D levels <12 ng/ml have higher mortality. Among other factors, severe vitamin D deficiency likely leads to poor outcome.

Keywords

• Vitamin D
• COVID-19
• mortality